Search For "serum"
NTAGI approves SII's Covovax COVID vaccine for 12-17 age group: Sources
Updated : 3 years, 10 months ago IST
New Delhi [India], April 29 (ANI): National Technical Advisory Group on Immunisation (NTAGI) on Friday approved Serum Institute of India's Covovax COVID-19 vaccine for the age group 12-17, said sources.
Read More
Indian jab in my arms, says UK PM; hails COVID-19 vaccine collaboration
Updated : 3 years, 10 months ago IST
New Delhi [India], April 22 (ANI): British Prime Minister Boris Johnson on Friday highlighted the collaboration between Oxford-Astra Zeneca and the Serum Institute of India (SII) for the production of COVID-19 vaccines and emphasised that he has "the Indian jab" in his arms.
Read More
Poonawalla Fincorp enters digital consumption loans space
Updated : 3 years, 11 months ago IST
Pune (Maharashtra) [India] April 19 (ANI/BusinessWire India): Poonawalla Fincorp Limited (Formerly Magma Fincorp Limited), has entered digital consumption loans space through a tie-up with KrazyBee. Under this partnership, Poonawalla Fincorp will offer small ticket personal loans to individu
Read More
Indian COVID vaccines better than Pfizer, Moderna says Adar Poonawalla
Updated : 3 years, 11 months ago IST
New Delhi [India], April 13 (ANI): Serum Institute of India (SII) CEO Adar Poonawalla on Wednesday claimed that "Made in India" COVID-19 vaccines have provided more protection against the coronavirus infection than mRNA vaccines like Pfizer and Moderna.
Read More
India is now better prepared to fight any Covid-19 variant, says SII's Ada
Updated : 3 years, 11 months ago IST
New Delhi [India], April 12 (ANI): As some countries are presently reporting higher COVID-19 cases, Chief Executive Officer of Serum Institute of India (SII) Adar Poonawalla on Tuesday said that India is better prepared to face it now than it was in 2020.
Read More
SII's Adar Poonawalla says Covovax first Indian COVID vaccine to be sold i
Updated : 3 years, 11 months ago IST
New Delhi [India], April 12 (ANI): Chief Executive Officer (CEO) of Serum Institute of India (SII) Adar Poonawalla on Tuesday informed that the company has exported nearly 40 million COVID vaccine doses to European countries and Australia, and said that the Covovax is the first vaccine made
Read More
Slashed COVID-19 vaccine Covishield's prices to ensure more accessibility,
Updated : 3 years, 11 months ago IST
New Delhi [India], April 12 (ANI): The decision to slash the prices of the precautionary dose of the COVID-19 vaccine Covishield, which is now available for all adults, was taken to make it more affordable, accessible and within reach of the masses, Chief Executive Officer (CEO) of Serum
Read More
Bharat Serums and Vaccines to invest Rs 200 crore in Genome Valley
Updated : 3 years, 11 months ago IST
Hyderabad (Telangana) [India], April 12 (ANI): Biopharmaceutical firm Bharat Serums and Vaccines Limited (BSV) on Tuesday said it would invest Rs 200 crore in the development of injectable and vaccine manufacturing facility at Genome Valley, India's first organised cluster for Life Sciences
Read More
COVID vaccine: Covishield's price reduced from Rs 600 to Rs 225 per dose a
Updated : 3 years, 11 months ago IST
Pune (Maharashtra) [India], April 9 (ANI): Pune-based Serum Institute of India (SII) on Saturday announced that it has revised the price of its COVID vaccine Covishield for private hospitals from Rs 600 to Rs 225 per dose.
Read More
Adar Poonawalla lauds Centre's work during COVID pandemic
Updated : 3 years, 11 months ago IST
Pune (Maharashtra) [India], April 4 (ANI): Amid the overall cases and positivity rate declining in the country and states like Maharashtra, West Bengal and Himachal Pradesh revoking the COVID restrictions, Adar Poonawalla, Chief Executive Officer (CEO) of Serum Institute of India (SII), p
Read More
Belviso announces launch of its premium skin care products in India
Updated : 3 years, 11 months ago IST
New Delhi [India], April 2 (ANI/PNN): On the auspicious occasion of Ugadi, Belviso announces the launch of its Premium Skin Care Product range in India. The products would be launched under the brand name Belviso. Launching initially are the Belviso Vitamin C Serum, Belviso Multi-Acid Serum,
Read More
NTAGI to review data of SII's COVID-19 vaccine Covovax on Friday: Sources
Updated : 3 years, 11 months ago IST
New Delhi [India], March 30 (ANI): The COVID-19 working group of the National Technical Advisory on Immunisation (NTAGI) will be reviewing the data of Serum Institute of India's vaccine -- Covovax for use for children and adults, on April 1, sources informed on Wednesday.
Read More